Ads
related to: epilepsy drug oxtellar xr- Adult Dosing
Read More About APTIOM®
Dosing For Adult Patients.
- Savings & Coverage
Read About the APTIOM® Savings
Program for Your Patients.
- Adverse Reactions
Learn More About Potential APTIOM®
Adverse Reactions Now.
- APTIOM® Video Library
Find A Video Library, Including
A Peer Perspective Video.
- APTIOM® Samples
Request APTIOM® Samples for
Your Patients.
- Formulary Coverage
View Formulary Coverage Info
For Your Patients.
- Adult Dosing
Search results
Epilepsy Medication: Types and Available Options
Verywell Health via Yahoo News· 8 months agoMedications that treat epilepsy vary based on the type of seizure disorder. There are two main types of epilepsy drugs: narrow-spectrum anti-epileptic...
Supernus Pharmaceuticals Inc (SUPN) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
GuruFocus.com via Yahoo Finance· 3 weeks agoTotal Revenue (Q1 2024): $143.6 million, a decrease from $153.8 million in the prior year quarter. Net Product Sales: $138.4 million, with a notable $19.3 million increase from Calgary offset ...
Mind-Bending Growth: 3 Psychedelic Stocks With Trippy Potential
InvestorPlace via Yahoo Finance· 5 months agoMental health has been one of the hot topics in the medical industry over the past few years....
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoSupernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2022 Earnings Call Transcript November 8, 2022...
Supernus Pharmaceuticals Reports Mixed Q1 2024 Results Amidst Strategic Shifts and Pipeline ...
GuruFocus.com via Yahoo Finance· 3 weeks agoTotal Revenue: Reported at $143.6 million, falling short of the estimated $145.83 million. Net Income: Reached $0.1 million, significantly below the estimated $20.73 million. Earnings Per Share ...
Ad
related to: epilepsy drug oxtellar xr